Overexpression of ERCC6L correlates with poor prognosis and confers malignant phenotypes of lung adenocarcinoma

Excision repair cross-complementation group 6 like (ERCC6L) has been reported to be upregulated in a variety of malignant tumors and plays a critical oncogenic role. However, the role and molecular mechanism of ERCC6L in lung adenocarcinoma (LUAD) remain unclear, and were therefore investigated in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiaoyue, Jiang, Lingyu, Lu, Sufang, Yuan, Mingqing, Lin, Hui, Li, Baijun, Wen, Zhaoke, Zhong, Yonglong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204608/
https://www.ncbi.nlm.nih.gov/pubmed/35656882
http://dx.doi.org/10.3892/or.2022.8342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204608/
https://www.ncbi.nlm.nih.gov/pubmed/35656882
http://dx.doi.org/10.3892/or.2022.8342

Ejemplares similares